SIRIUSPOINT LTD (SPNT)
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SPNT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SPNT | Director | 60 | ["Co-founder and managing partner of Seae Ventures","Chief Strategy Officer of Blue Cross Blue Shield of Massachusetts","President and CEO of Zaffre Investments","Executive Vice President at Health Dialog","Principal at Mercer Human Resource Consulting","Vice President at Imagitas","President at Ceridian Performance Partners Canada","Extensive experience in business strategy, healthcare, venture investing, digital strategy and human capital management"] | ["Governance & Nominating","Compensation","Investment","Governance & Nominating Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Jason Robart has served as a member of the Board since March 2022. Mr. Robart is the co-founder and managing partner of Seae Ventures, an early-stage venture capital firm. Prior to co-founding Seae Ventures in 2019, Mr. Robart served as the Chief Strategy Officer of Blue Cross Blue Shield of Massachusetts and President and CEO of Zaffre Investments, a wholly-owned subsidiary of Blue Cross Blue Shield of Massachusetts. In addition, Mr. Robart served as Executive Vice President at Health Dialog, Principal at Mercer Human Resource Consulting, Vice President at Imagitas and President at Ceridian Performance Partners Canada. Mr. Robart serves on the private boards of Blue Cross Blue Shield, Vermont and several Seae companies, including Hurdle, Kiyatec, MyMeds and ScriptSee. Mr. Robart holds a Bachelor s degree in political science from Middlebury College. The Board considered Mr. Robart s extensive experience as an accomplished executive and substantial experience in a range of areas including business strategy, healthcare, venture investing, digital strategy and human capital management. The Board concluded that he should continue to serve on the Board because he brings extensive leadership experience in developing early stage growth and health insurance companies to the Board and his deep experience in human capital management.